{
    "2019-01-16": [
        [
            {
                "time": "2018-12-31",
                "original_text": "Health Care Stocks in Gurus' Portfolios",
                "features": {
                    "keywords": [
                        "health care",
                        "gurus",
                        "portfolios"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings",
                "features": {
                    "keywords": [
                        "Kitov Pharma",
                        "anti-cancer",
                        "findings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Intrexon Signs Licensing Agreement with Next Green Wave",
                "features": {
                    "keywords": [
                        "Intrexon",
                        "licensing agreement",
                        "Next Green Wave"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It",
                "features": {
                    "keywords": [
                        "Ligand",
                        "short-seller",
                        "crashes"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Goldman's Gold Standard in M&A Bolsters Outlook for 2019",
                "features": {
                    "keywords": [
                        "Goldman",
                        "M&A",
                        "outlook"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Takeda Wraps Its Shire Buyout, CEO Sees More Mergers Coming",
                "features": {
                    "keywords": [
                        "Takeda",
                        "Shire",
                        "mergers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "buy",
                        "reasons"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}